MedPath

Changes of Left Atrial Function and Quality of Life After Transcatheter Closure of Left Atrial Appendage in Patients With Atrial Fibrillation

Not Applicable
Completed
Conditions
Atrial Fibrillation
Interventions
Procedure: Left atrial appendage closure
Procedure: Radiofrequency ablation
Procedure: LAAC combined with radiofrequency ablation group
Registration Number
NCT04376606
Lead Sponsor
Ruiqin xie
Brief Summary

A total of 105 (AF) patients with atrial fibrillation are scheduled to undergo surgery and will be divided into three groups. Left atrial appendage occlusion ((LAAC)), radiofrequency ablation guided by three-dimensional mapping and LAAC combined with radiofrequency ablation were performed respectively (allocation ratio 1:1:1). All patients were examined by real-time three-dimensional and two-dimensional ultrasound before operation and 3, 6 and 12 months after operation, and the (LA) function of left atrium was measured. All ultrasound data will be stored and the professional director of the ultrasound room will be invited to conduct quantitative analysis. Ultrasonic examination indexes include: anterior and posterior diameter of left atrium, left atrial ejection fraction and so on. All patients underwent transesophageal echocardiography before and 3 months after operation. The results were interpreted by 2 experienced ultrasound doctors to measure the presence of left atrial thrombus, residual shunt and device-related thrombus. Blood samples were taken to detect B-type natriuretic peptide before operation, 1 day, 3-6 months and 12 months after operation. All patients underwent 6-minute walking test and quality of life score before operation and 3, 6 and 12 months after operation. At the same time, the thickness of crest in all patients was measured during operation. This study will clarify the changes of left atrial function and quality of life in patients with atrial fibrillation after LAAC. In addition, this study also observed the effect of radiofrequency ablation combined with LAAC on left atrial function and evaluated whether one-stop surgery was superior to simple occlusion or ablation, and the above results were analyzed. The patients were followed up for an average of one year, and the changes of left atrial function, quality of life and embolic events were analyzed.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
105
Inclusion Criteria

sustained AF attack occurred in patients with a duration of more than one year, patients taking class I and class III antiarrhythmic drugs could not prevent AF, patients younger than 80 years old, Cha2ds2-vasc score ≥2, not suitable for long-term oral anticoagulant drugs.

Exclusion Criteria

Patients with a history of atrial thrombosis or valvular heart disease (moderate or severe valve stenosis or severe valve regurgitation), patients undergoing prosthetic heart valve replacement, pregnant women, patients with previous liver and kidney diseases, malignant tumors or blood system diseases.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Left atrial appendage closure groupLeft atrial appendage closure-
Radiofrequency ablation groupRadiofrequency ablation-
LAAC combined with radiofrequency ablation groupLAAC combined with radiofrequency ablation group-
Primary Outcome Measures
NameTimeMethod
Left atrial function of postoperative left atrial appendage occlusion detected1-12 months

Transthoracic echocardiography

quality of life score test1-12 months

quality of life assessed

6-minute walking test1-12 months

quality of life assessed

Secondary Outcome Measures
NameTimeMethod
residual shunt and DRT after transcatheter closure of left atrial appendage detected1-12 months

Transesophageal echocardiography

B natriuretic peptide assessed1-12 months

Blood samples are extracted in all patients to detected

Trial Locations

Locations (1)

The Second Hospital of Hebei Medical University

🇨🇳

Shijiazhuang, Hebei, China

© Copyright 2025. All Rights Reserved by MedPath